Exercise capacity and quality of life in the treatment of heart failure

R Blackwood1, R A Mayou, J C Garnham

  • 1Cardiac Research Unit, Wexham Park Hospital, Slough.

Insights

Heart failure patients showed similar improvements in exercise and quality of life across active treatments and placebo. Special heart failure clinics may offer therapeutic benefits beyond medication.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Quality of Life Research

Background:

  • The relationship between exercise capacity and symptomatic/functional status in heart failure patients remains unclear.
  • Evaluating treatment efficacy requires robust measures of both exercise capacity and quality of life.

Purpose of the Study:

  • To compare the effects of digoxin, xamoterol, and placebo on exercise capacity and quality of life in heart failure patients.
  • To establish quantitative measures for quality-of-life variables and assess their correlation with exercise capacity.
  • To validate the use of exercise capacity and quality-of-life measurements in heart failure treatment evaluation.

Main Methods:

  • A double-blind, placebo-controlled study involving patients with heart failure.
  • Comparison of two active treatments (digoxin and xamoterol) against a placebo.
  • Development and application of quantitative measures for quality-of-life variables.

Main Results:

  • All groups, including placebo, demonstrated improvements in exercise capacity and quality of life without significant differences between treatments.
  • The placebo effect was substantial, likely due to increased medical and research staff attention, highlighting the value of specialized heart failure clinics.
  • Significant correlations were found between changes in exercise duration and various quality-of-life indicators (e.g., breathlessness, mood, daily task difficulty).

Conclusions:

  • Measuring changes in exercise capacity is a valid approach for evaluating heart failure treatment.
  • Quantitative quality-of-life measurements significantly contribute to the comprehensive assessment of heart failure therapies.
  • The attention provided in specialized heart failure clinics may have a considerable therapeutic impact on patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...